Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain

Brain Research

Volumn 1231, Issue , 2008, Pages 6-15

  Liang, Yanqi ^a   Boules, Mona ^a   Shaw, Amanda M ^a   Williams, Katrina ^a   Fredrickson, Paul ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

Author keywords

Medial prefrontal cortex; Microdialysis; Monoamine; Nicotine; NT69L; Nucleus accumbens

Indexed keywords

DOPAMINE; NEUROTENSIN 69L; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; NEUROTENSIN[8-13]; NICOTINE; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MEDIAL PREFRONTAL CORTEX; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TOBACCO DEPENDENCE;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; DOPAMINE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; LIMBIC SYSTEM; MALE; MICRODIALYSIS; NEURAL PATHWAYS; NEUROTENSIN; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PEPTIDE FRAGMENTS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TOBACCO USE DISORDER;

RATTUS;

EID: 50649111160     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.037     Document Type: Article

References (44)

1. Balfour D.J. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine Tob. Res. 6 (2004) 899-912
2. Balfour D.J., Benwell M.E., Birrell C.E., Kelly R.J., and Al-Aloul M. Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol. Biochem. Behav. 59 (1998) 1021-1030
3. Balfour D.J., Wright A.E., Benwell M.E., and Birrell C.E. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav. Brain Res. 113 (2000) 73-83
4. Bauco P., and Rompre P.P. Effects of neurotensin receptor activation on brain stimulation reward in Fischer 344 and Lewis rats. Eur. J. Pharmacol. 432 (2001) 57-61
5. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998) 309-369
6. Boudin H., Pelaprat D., Rostene W., and Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373 (1996) 76-89
7. Boules M., Warrington L., Fauq A., McCormick D., and Richelson E. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. Eur. J. Pharmacol. 428 (2001) 227-233
8. Boules M., Fredrickson P., and Richelson E. Current topics: brain penetrating neurotensin analog. Life Sci. 73 (2003) 2785-2792
9. Boules M., Fredrickson P., and Richelson E. Bioactive analogs of neurotensin. Peptides 27 (2006) 2523-2533
10. Boules M., Iversen I., Oliveros A., Shaw A., Williams K., Fredrickson P., and Richelson E. The neurotensin agonist, NT69L, suppresses sucrose-reinforced operant behavior in the rat. Brain Res. 1127 (2007) 90-98
11. Brown P., and Molliver M.E. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J. Neurosci. 20 (2000) 1952-1963
12. Caceda R., Kinkead B., and Nemeroff C.B. Neurotensin: role in psychiatric and neurological diseases. Peptides. 27 (2006) 2385-2404
13. Carraway R., and Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248 (1973) 6854-6861
14. Corrigall W.A., and Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl). 99 (1989) 473-478
15. Corrigall W.A., Franklin K.B., Coen K.M., and Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107 (1992) 285-289
16. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393 (2000) 295-314
17. Ford A.P., and Marsden C.A. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Brain Res. 534 (1990) 243-250
18. Fredrickson P., Boules M., Yerbury S., and Richelson E. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Eur. J. Pharmacol. 458 (2003) 111-118
19. Fredrickson P., Boules M., Yerbury S., and Richelson E. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. Brain Res. 979 (2003) 245-248
20. Giniatullin R., Nistri A., and Yakel J.L. Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci. 28 (2005) 371-378
21. Gothert M. Presynaptic serotonin receptors in the central nervous system. Ann. N. Y. Acad. Sci. 604 (1990) 102-112
22. Iyaniwura T.T., Wright A.E., and Balfour D.J. Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain. Psychopharmacology (Berl) 158 (2001) 73-79
23. Kinkead B., Binder E.B., and Nemeroff C.B. Does neurotensin mediate the effects of antipsychotic drugs?. Biol. Psychiatry 46 (1999) 340-351
24. Miller D.K., Wilkins L.H., Bardo M.T., Crooks P.A., and Dwoskin L.P. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology (Berl) 156 (2001) 469-476
25. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res. 434 (1987) 117-165
26. Olausson P., Akesson P., Petersson A., Engel J.A., and Soderpalm B. Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacology (Berl) 155 (2001) 348-361
27. Pan W.H., Yang S.Y., and Lin S.K. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 53 (2004) 44-52
28. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, Sydney
29. Pontieri F.E., Tanda G., Orzi F., and Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382 (1996) 255-257
30. Robledo P., Maldonado R., and Koob G.F. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res. 622 (1993) 105-112
31. Sarret P., Krzywkowski P., Segal L., Nielsen M.S., Petersen C.M., Mazella J., Stroh T., and Beaudet A. Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system. J. Comp. Neurol. 461 (2003) 483-505
32. Sarret P., Perron A., Stroh T., and Beaudet A. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J. Comp. Neurol. 461 (2003) 520-538
33. Schultz W., Tremblay L., and Hollerman J.R. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37 (1998) 421-429
34. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., and Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18 (1998) 2697-2708
35. Singer S., Rossi S., Verzosa S., Hashim A., Lonow R., Cooper T., Sershen H., and Lajtha A. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function. Neurochem. Res. 29 (2004) 1779-1792
36. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res. Brain Res. Rev. 41 (2003) 203-228
37. St-Gelais F., Jomphe C., and Trudeau L.E. The role of neurotensin in central nervous system pathophysiology: what is the evidence?. J. Psychiatry Neurosci. 31 (2006) 229-245
38. Summers K.L., and Giacobini E. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem. Res. 20 (1995) 753-759
39. Tassin J.P., Trovero F., Herve D., Blanc G., and Glowinski J. Biochemical and behavioural consequences of interactions between dopaminergic and noradrenergic systems in rat prefrontal cortex. Neurochem. Int. 20 (Suppl.) (1992) 225S-230S
40. Tyler-McMahon B.M., Boules M., and Richelson E. Neurotensin: peptide for the next millennium. Regul. Pept. 93 (2000) 125-136
41. Van Bockstaele E.J., and Pickel V.M. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. Comp. Neurol. 334 (1993) 603-617
42. Ventura R., Morrone C., and Puglisi-Allegra S. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5181-5186
43. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., and Richter R.R. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N. Y. Acad. Sci. 937 (2001) 1-26
44. Yamamoto B.K., and Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71 (1998) 274-280